Organization | Michigan State University

Michigan State University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: East Lansing MI United States (1855)

Organization Overview

First Clinical Trial

2004

NCT00119002

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Fiechtner, Justus J., M.D., P.C. | Gary E. Stein, Pharm.D. | Helen DeVos Children's Hospital | Helen DeVos Childrens Hospital | Helen DeVos Children's Hospital at Spectrum Health | Helen DeVos Children's Hospital of Spectrum Health Hospitals | Justus Fiechtner MD PC | Justus J. Fiechtner, MD, PC | Michigan State University | MichiganState University | Michigan State University. Assistant Chair-Dept of Obstetrics, Gynecology&Reproductive Biology

Active Ingredients

Drugs in Phase 4 Trials (19)

acetaminophen (tylenol) (2 trials)

caspofungin (cancidas) (1 trial)

ceftaroline fosamil (teflaro) (1 trial)

clozapine (clozaril) (1 trial)

corticotropin (acthar) (2 trials)

doripenem (doribax) (1 trial)

doxycycline (vibramycin) (1 trial)

insulin glulisine (Apidra) (1 trial)

insulin lispro (humalog) (1 trial)

ketorolac (acuvail) (1 trial)

levofloxacin (levaquin) (2 trials)

micafungin (mycamine) (1 trial)

midazolam (versed) (1 trial)

multi-valent pneumococcal conjugate vaccine (1 trial)

propofol (diprivan) (1 trial)

ranibizumab (lucentis) (1 trial)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

risperidone (risperdal) (2 trials)

Drugs in Phase 3 Trials (4)

amlodipine (norvasc) (3 trials)

atorvastatin (lipitor) (1 trial)

losartan (cozaar) (3 trials)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (14)

celecoxib (celebrex) (1 trial)

daclizumab (Zenapax) (1 trial)

daratumumab (darzalex) (1 trial)

desipramine (pertofrane) (1 trial)

fluoxetine (prozac) (1 trial)

fontolizumab (1 trial)

insulin aspart (Novolog) (1 trial)

interferon alpha-2b (Intron-A) (1 trial)

sargramostim (leukine) (1 trial)

saw palmetto (1 trial)

temozolomide (temodar) (1 trial)

topotecan (hycamtin) (1 trial)

vincristine (oncovin) (1 trial)

vismodegib (erivedge) (1 trial)

Drugs in Phase 1 Trials (5)

avibactam (Avycaz) (1 trial)

ceftazidime (fortaz) (1 trial)

human fecal microbiota (Reybota) (1 trial)

magnesium oxide (1 trial)

ondansetron (zofran) (1 trial)

Drugs in Other Trials (5)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

inactivated influenza vaccine (1 trial)

soybean (1 trial)

tigecycline (tygacil) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Alcoholism (Phase 2)

Alzheimer Disease (Phase 3)

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 4)

Arthritis, Rheumatoid (Phase 2)

Brain Edema (Phase 3)

Brain Injuries (Phase 4)

Brain Injuries, Traumatic (Phase 4)

Bronchiolitis (Phase 4)

Bronchiolitis, Viral (Phase 4)

Candidemia (Phase 4)

Central Nervous System Neoplasms (Phase 2)

Cognitive Dysfunction (Phase 3)

Critical Illness (Phase 1)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Edema (Phase 4)

Emergencies (Phase 4)

Febrile Neutropenia (Phase 4)

Fever (Phase 4)

Glioma (Phase 2)

Headache (Phase 4)

Hypertension (Phase 2)

Infertility (Phase 4)

Inflammatory Bowel Diseases (Phase 1)

Intestinal Diseases (Phase 1)

Intracranial Hypertension (Phase 2)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Lupus Erythematosus, Systemic (Phase 4)

Macular Edema (Phase 4)

Malaria (Phase 3)

Malaria, Cerebral (Phase 3)

Marijuana Abuse (Phase 4)

Multiple Sclerosis (Phase 2)

Nervous System Neoplasms (Phase 2)

Neurofibroma (Phase 2)

Neurofibromatoses (Phase 2)

Neurofibromatosis 1 (Phase 2)

Neutropenia (Phase 4)

Pneumonia (Phase 4)

Pneumonia, Bacterial (Phase 4)

Post-Concussion Syndrome (Phase 1)

Prostatic Neoplasms (Phase 2)

Schizophrenia (Phase 4)

Sclerosis (Phase 2)

Wounds and Injuries (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 36
# of Trial APIs: 47